Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
NCT06535334 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2024-08-02
Summary
This study aims to compare intravenous chemotherapy versus intraperitoneal chemotherapy in patients with recurrent ovarian cancer.
Conditions
- Intravenous Chemotherapy Versus Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
Interventions
- DRUG
-
Intravenous chemotherapy versus intraperitoneal chemotherapy in recurrent ovarian cancer
Sponsors & Collaborators
-
Far Eastern Memorial Hospital
lead OTHER
Eligibility
- Min Age
- 20 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-08-15
- Primary Completion
- 2025-06-30
- Completion
- 2026-05-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study
NCT00968799 ·Status: TERMINATED ·Phase: NA
-
Postoperative Adjuvant Chemotherapy With Bevacizumab and Maintenance Bevacizumab After Neoadjuvant Chemotherapy for Ovarian Cancer
NCT02022917 ·Status: COMPLETED ·Phase: PHASE2
-
Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer
NCT00660842 ·Status: UNKNOWN ·Phase: PHASE3
-
OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study
NCT06611072 ·Status: RECRUITING ·Phase: NA
-
The Analyses of Treatment Efficacy and Cost-effectiveness in Early-staged Ovarian Cancer Patients
NCT03019315 ·Status: UNKNOWN
-
Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer
NCT00006356 ·Status: TERMINATED ·Phase: PHASE3
-
Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancer
NCT05633199 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Assessment of Mesothelin Antigen Specific Immunologic Assays in Ovarian Cancer Patients
NCT00173394 ·Status: UNKNOWN
-
IPHC in Patients With Platinum-sensitive Recurrent Ovarian Cancer
NCT01588964 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Chemotherapy Given Either by Mouth or by Infusion on the Quality of Life of Patients With Recurrent Ovarian Epithelial Cancer
NCT00004909 ·Status: COMPLETED
-
First-line Intraperitoneal Cisplatin and Etoposide Chemotherapy for Ovarian Cancer
NCT01669226 ·Status: COMPLETED ·Phase: PHASE2
-
Intra-peritoneal Chemotherapy in Ovarian Cancer
NCT02861872 ·Status: UNKNOWN
-
Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
NCT00003358 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer
NCT04337632 ·Status: UNKNOWN ·Phase: PHASE3
-
Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment
NCT02035345 ·Status: TERMINATED ·Phase: PHASE4
-
Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial
NCT01506856 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer
NCT03949283 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of DP303c Injection in Patients With Advanced Ovarian Cancer
NCT04828616 ·Status: UNKNOWN ·Phase: PHASE2
-
Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer
NCT00093496 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval
NCT00657878 ·Status: UNKNOWN ·Phase: PHASE3
-
Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy
NCT03491033 ·Status: COMPLETED
-
Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
NCT01652794 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary
NCT06279104 ·Status: RECRUITING
-
An INternational Frontline Ovarian Cancer Real World Management Study
NCT04460768 ·Status: COMPLETED
-
Surgery for Relapsed Ovarian Cancer in Precision
NCT06602063 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2